Non-alcoholic fatty liver disease(NAFLD),defined as the presence of fat accumulation in imaging or histology in more than 5%of hepatocytes and exclusion of other causes for secondary hepatic fat accumulation,is one of...
This work was supported by the Major Program of National Natural Science Foundation of China(81991525);Key R&D Program of Shandong Province(2020CXGC010503);This work was also supported by grants from the National Institutes of Health(R00AA026648 to K.L.P.).
Non-alcohol-associated fatty liver/steatohepatitis(NAFL/NASH)has become the leading cause of liver disease worldwide.NASH,an advanced form of NAFL,can be progressive and more susceptible to developing cirrhosis and he...
Nonalcoholic fatty liver disease (NAFLD) is a hepatic mani-festation of metabolic syndrome. The spread of obesity worldwide in pandemic proportions has led to a rapid rise of NAFLD in developed and developing countrie...
Nonalcoholic fatty liver disease(NAFLD)represents a major public health epidemic.Pharmacologic therapies for this condition are scarce,but multiple agents with novel mechanisms of action are in development.Here we rev...